Get email alerts when DFTX insiders make a move — free, no credit card

DFTX Insider Trading & Form 4 Activity

Definium Therapeutics, Inc.
Last filing: Jun 26, 2026·12 days ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking DFTX insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Barrow Robert
Chief Executive Officer
$1.3M
-$1.3M
Sullivan Mark
Chief Legal Officer
$586K
-$586K
Karlin Daniel
Chief Medical Officer
$452K
-$452K
Roberts Brandi
Chief Financial Officer
$136K
-$136K
Wiley Matthew T.
Chief Commercial Officer
$129K
-$129K
Krebs Andreas
Director
$0
Vallone Carol A
Director
$0
Bruhn Suzanne Louise
Director
$0

Recent transactions

Every Form 4 transaction for DFTX, newest first.

SELL10b5-1
Sullivan Mark · Chief Legal Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
13,008 sh @ $45.03
$586K
SELL10b5-1
Wiley Matthew T. · Chief Commercial Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
2,867 sh @ $45.03
$129K
SELL10b5-1
Barrow Robert · Chief Executive Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
29,208 sh @ $45.03
$1.3M
SELL10b5-1
Roberts Brandi · Chief Financial Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
3,013 sh @ $45.03
$136K
SELL10b5-1
Karlin Daniel · Chief Medical Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
10,035 sh @ $45.03
$452K
AWARD
Barrow Robert · Chief Executive Officer
Tx Jun 22·Filed Jun 22·EDGAR ↗
375,000 sh
AWARD
Roberts Brandi · Chief Financial Officer
Tx Jun 22·Filed Jun 22·EDGAR ↗
62,500 sh
AWARD
Sullivan Mark · Chief Legal Officer
Tx Jun 22·Filed Jun 22·EDGAR ↗
62,500 sh
AWARD
Karlin Daniel · Chief Medical Officer
Tx Jun 22·Filed Jun 22·EDGAR ↗
100,000 sh
AWARD
Wiley Matthew T. · Chief Commercial Officer
Tx Jun 22·Filed Jun 22·EDGAR ↗
62,500 sh
AWARD
Krebs Andreas · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
4,666 sh
AWARD
Vallone Carol A · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
4,666 sh
AWARD
Bruhn Suzanne Louise · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
4,666 sh
AWARD
Gryska David W · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
4,666 sh
AWARD
Crystal Roger · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
4,666 sh
AWARD
Adsett Roger · Director
Tx Jun 11·Filed Jun 15·EDGAR ↗
3,555 sh

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About DFTX insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for DFTX from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying DFTX always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Definium Therapeutics, Inc. (DFTX) when they form.

Where does DFTX insider trading data come from?

Every Form 4 filing for DFTX is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai